Print
Email
Print Edition StoriesLooking to grow, Burlington-based medical device startup CorNova Inc. has enlarged its management team by appointing a new CFO and senior scientist. The company says it has named Robert Gallahue as CFO, and added Richard Sahagian as senior scientist.
To become a more advanced development and sales company, CorNova required adding financial expertise, said S. Eric Ryan, CorNova CEO, in a statement. Gallahue, who has 20 years of financial management experience in life sciences and medical technology companies, will assist CorNova in its required maturation, claimed Ryan.
The company is evolving its endovascular product line, including the FiberHalo stent deployment and post-dilatation balloon catheter, the FiberHalo pre-dilatation balloon catheter, and the advanced Valecor Platinum Coronary Stent System.
Sahagian has more than two decades’ worth of experience in medical device development and production. In his job, he will oversee production of the Valecor Platinum Coronary Stent (a platinum surface-modified stent), and manage the research and development of advanced surface modification technologies. Before joining CorNova, he founded the medical device division at Implant Sciences Corp.
CorNova’s next-generation endovascular products are designed to integrate new technologies into existing products and procedures, but without adding procedure time, cost and patient risk. CorNova was launched in 2005 by Wakefield-based Implant Sciences, which makes sensors for the homeland security and defense markets, and Wilmington-based medical device firm CardioTech International Inc.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
RSS Feeds
